Clinical Trials for the Effects of Polygoni Multiflori Radix Complex Extract on Memory Improvement

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

54 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to identify the effect of Polygoni Multiflori Radix complex extract on memory improvement using Rey-Kim scale for healthy people.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Development and Evaluation of a Cognitive Enhancement Product Made From Selected Thai Herbs for Menopausal Women

NCT02567760

Healthy

COMPLETED PHASE1

Evaluation of Consumption Safety and Effect of Mulberry Leaves and Vietnamese Coriander Based Instant Polyherbal Porridge on Working Memory and Bone Formation Markers

NCT02562274

Healthy

COMPLETED PHASE1

Efficacy and Safety of Platycodon Grandiflorus Extract(GCWB107) on Decrease of Body Fat

NCT04023864

Body Fat

UNKNOWN NA

The Effect of Oral Use of Lyophilised Royal Jelly on Cognitive Functions and Immune System in Elderly Individuals

NCT06404203

Cognitive Change

UNKNOWN NA

A 12-week Human Trial to Compare the Efficacy and Safety of Polycan on Bone Metabolism

NCT01402115

Bone Health in Perimenopausal Women

COMPLETED PHASE2/PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Memory, Short-Term

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Polygoni Multiflori Radix complex

Participants randomized to the experimental group will take one capsule of Polygoni Multiflori Radix complex extract (250mg) twice a day, 30 minutes after breakfast and dinner for 4 weeks.

Group Type EXPERIMENTAL

Polygoni Multiflori Radix complex extract

Intervention Type DIETARY_SUPPLEMENT

Intervention is manufactured by Chun-Ho food

Starch

Participants randomized to the placebo group will take one capsule of placebo(250mg) twice a day, 30 minutes after breakfast and dinner for 4 weeks.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

The placebo is filled with starch, so does not contain the active ingredient.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Polygoni Multiflori Radix complex extract

Intervention is manufactured by Chun-Ho food

Intervention Type DIETARY_SUPPLEMENT

Placebo

The placebo is filled with starch, so does not contain the active ingredient.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A person who is more than 50 years and lesser than 70 years of age
* A person who's MQ(Memory Quotient) score is within more than 70 and lesser than 120

Exclusion Criteria

* The patient who has past history related to memory
* The patient who has Diabetes Mellitus
* The person whose fasting blood sugar is more than 126mg/dL
* The patients who has uncontrolled hypertension
* The patient who has liver disorders
* The patient whose AST(aspartate aminotransferase) or ALT(alanine aminotransferase) level is more than 60 IU/L(international units per liter)
* The patients who has heart disorders (Angina pectoris, Myocardial infarction)
* The patient who has past history related to excision of G-I tract excluding cecum
* The patient who took drug or heal functional food within 4 weeks before screening
* The patient who took decoction of herb within 4 weeks before screening
* The patient who can't write or communicate
* pregnant woman

Minimum Eligible Age

50 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes